Zobrazeno 1 - 10
of 272
pro vyhledávání: '"Dawn C. Buse"'
Autor:
Dawn C. Buse, Roger Cady, Amaal J. Starling, Meghan Buzby, Charlie Spinale, Kathy Steinberg, Kevin Lenaburg, Steven Kymes
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background High-frequency headache/migraine (HFM) and overuse of acute medication (medication overuse [MO]) are associated with increased disability and impact. Experiencing both HFM and MO can potentially compound impacts, including stigma;
Externí odkaz:
https://doaj.org/article/b8463904d42c44fbba5e3462032a8cd1
Autor:
Dawn C. Buse, Lynda J. Krasenbaum, Michael J. Seminerio, Elizabeth R. Packnett, Karen Carr, Mario Ortega, Maurice T. Driessen
Publikováno v:
Pain and Therapy, Vol 13, Iss 3, Pp 511-532 (2024)
Abstract Introduction Fremanezumab, a humanized monoclonal antibody targeting calcitonin gene-related peptide, is indicated for preventive treatment of migraine in adults. Real-world evidence assessing the effect of fremanezumab on migraine-related m
Externí odkaz:
https://doaj.org/article/aeda1e44684544f0a9b15d1d6e0a6b31
Autor:
Amaal J. Starling, Roger Cady, Dawn C. Buse, Meghan Buzby, Charlie Spinale, Kathy Steinberg, Kevin Lenaburg, Steven Kymes
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-14 (2024)
Abstract Background Migraine is a disabling neurologic disease that can fluctuate over time in severity, frequency, and acute medication use. Harris Poll Migraine Report Card was a US population-based survey to ascertain quantifiable distinctions amo
Externí odkaz:
https://doaj.org/article/f6d2ea6da8204c00ab109e81db1a5cfb
Autor:
Richard B. Lipton, Michel Lanteri-Minet, Elizabeth Leroux, Aubrey Manack Adams, Janette Contreras-De Lama, Michael L. Reed, Kristina M. Fanning, Dawn C. Buse
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background Individuals with migraine frequently experience pre- and post-headache symptoms. This analysis aimed to characterize the relative frequency and burden of pre- and post-headache symptoms in people with migraine using data collected
Externí odkaz:
https://doaj.org/article/0e21e9a15c754aaaa9db1d6f68b8daaf
Autor:
Dawn C. Buse, Patricia Pozo-Rosich, Laure Dupont-Benjamin, Bridget L. Balkaran, Lulu Lee, Adam Jauregui, Pranav Gandhi, Mousam Parikh, Uwe Reuter
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-14 (2023)
Abstract Background Data are limited regarding the combined impact of headache frequency and failure of preventive medication (efficacy and/or tolerability) on the humanistic/economic burden of migraine. Methods A retrospective, cross-sectional analy
Externí odkaz:
https://doaj.org/article/4083813eefd7469ba7aecd58c9c98e99
Autor:
Janet H. Ford, Wenyu Ye, David W. Ayer, Xiaojuan Mi, Swati Bhandari, Dawn C. Buse, Richard B. Lipton
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-15 (2023)
Abstract Background No available studies demonstrate validity and meaningful change thresholds of Work Productivity and Activity Impairment (WPAI) questionnaire in patients with migraine. In this post-hoc analysis, we assessed reliability, validity,
Externí odkaz:
https://doaj.org/article/9cc0c676c6dc4733ae10cfbe5f41aaf3
Autor:
Roger Cady, Richard B. Lipton, Dawn C. Buse, Mette Krog Josiassen, Annika Lindsten, Anders Ettrup
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background The benefits of preventive treatment on the effectiveness of migraine management have rarely been examined. This post hoc analysis investigated the impact of eptinezumab on the optimization of acute medication effectiveness using
Externí odkaz:
https://doaj.org/article/7294224df94c4a88a383591a4d4856b6
Publikováno v:
Frontiers in Neurology, Vol 13 (2023)
BackgroundProphylactic medication in clinical detoxification programs for the treatment of medication overuse headache is still debated. Gastrodin, a main bioactive constituent of Rhizoma Gastrodiae, has been applied clinically to treat primary heada
Externí odkaz:
https://doaj.org/article/04537c82a8e248eb9febd65669fbc9e4
Autor:
Peter McAllister, Paul K. Winner, Jessica Ailani, Dawn C. Buse, Richard B. Lipton, George Chakhava, Mette Krog Josiassen, Annika Lindsten, Lahar Mehta, Anders Ettrup, Roger Cady
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Demonstrating therapeutic value from the patient perspective is important in patient-centered migraine management. The objective of this study was to investigate the impact of eptinezumab, a preventive migraine treatment, on patie
Externí odkaz:
https://doaj.org/article/01048f33773d406b8c9421698d8a7692
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background A clinical ability to describe the response trajectory of patients receiving preventive migraine treatment could expedite and improve therapeutic management decisions. This post hoc analysis of the PROMISE-2 study evaluated the co
Externí odkaz:
https://doaj.org/article/5115f9d7b341495eb41d3dac23d97a10